PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.\', \'Department of Pharmacy, Mayo Clinic, Rochester, MN, 55905, USA.\', \'Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.\', \'Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Gajic.ognjen@mayo.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13054-021-03873-2
?:hasPublicationType
?:journal
  • Critical care (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34983600
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34983600>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34983600>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all